Prevalence of NNRTI DRMs in ARV-Naive Patients
Last updated on 2015-2-9
L100I, K101P, K103N/S, V106A/M, Y181C/I/V, Y188C/H/L, G190A/E/Q/S, M230L
Table 6a. Prevalence of major NNRTI DRMs in ARV-naive patients by region
Sub-Saharan Africa n=11628 361 with major DRMs | South/Southeast Asia n=6830 146 with major DRMs | Latin America n=5715 225 with major DRMs | Upper-income countries n=24898 1089 with major DRMs |
| DRM | DRM% | DRM% Sum | DRM | DRM% | DRM% Sum | DRM | DRM% | DRM% Sum | DRM | DRM% | DRM% Sum |
| K103N | 57.5 | 57.5 | Y181C | 41.4 | 41.4 | K103N | 63.0 | 63.0 | K103N | 67.0 | 67.0 |
| Y181C | 20.6 | 73.7 | K103N | 37.4 | 76.8 | Y181C | 17.3 | 77.2 | Y181C | 14.7 | 78.0 |
| G190A | 18.0 | 86.8 | G190A | 17.2 | 84.8 | G190A | 13.6 | 85.8 | G190A | 11.7 | 86.4 |
| L100I | 3.1 | 89.5 | V106M | 5.1 | 88.9 | Y188L | 6.2 | 91.4 | Y188L | 5.1 | 90.5 |
| G190E | 2.2 | 91.7 | V106A | 2.0 | 90.9 | G190S | 3.7 | 94.4 | K103S | 3.4 | 92.2 |
| K103S | 3.1 | 93.4 | K103S | 7.1 | 92.9 | K103S | 4.3 | 96.3 | Y188H | 1.6 | 93.6 |
| Y188L | 1.3 | 94.7 | G190E | 2.0 | 94.9 | Y188C | 1.2 | 97.5 | Y188C | 1.4 | 94.9 |
| V106M | 1.3 | 95.6 | Y188L | 2.0 | 97.0 | M230L | 4.9 | 98.8 | V106A | 1.6 | 96.0 |
| V106A | 0.9 | 96.5 | M230L | 1.0 | 98.0 | V106M | 1.2 | 99.4 | V106M | 1.1 | 97.0 |
| Y188C | 1.3 | 97.4 | G190S | 2.0 | 99.0 | Y181V | 0.6 | 100.0 | G190S | 1.3 | 97.8 |
| Y181I | 0.9 | 98.2 | Y181I | 1.0 | 100.0 | L100I | 1.2 | - | G190E | 0.8 | 98.7 |
| Y188H | 0.9 | 99.1 | Y188C | 1.0 | - | K101P | 1.2 | - | M230L | 0.8 | 99.2 |
| M230L | 0.4 | 99.6 | L100I | 0.0 | - | V106A | 0.6 | - | Y181I | 1.0 | 99.6 |
| G190S | 0.4 | 100.0 | G190Q | 0.0 | - | Y188H | 0.6 | - | L100I | 2.4 | 99.9 |
| Y181V | 0.9 | - | K101P | 0.0 | - | G190Q | 0.0 | - | K101P | 1.1 | 100.0 |
| K101P | 0.4 | - | Y181V | 0.0 | - | G190E | 0.0 | - | Y181V | 0.1 | - |
| G190Q | 0.0 | - | Y188H | 0.0 | - | Y181I | 0.0 | - | G190Q | 0.0 | - |
Footnotes:
- The prevalence of all DRMs including those with lower scores can be queried using the form at the following page: Prevalence of DRMs in ARV-Naive Patients
Table 6b. Prevalence of major NNRTI DRMs in ARV-naive patients by subtype
A n=3408 39 with major DRMs | B n=26882 644 with major DRMs | C n=7519 72 with major DRMs | D n=1295 21 with major DRMs | G n=1450 11 with major DRMs | 01 n=5499 35 with major DRMs | 02 n=2706 28 with major DRMs |
| DRM | DRM% | DRM% Sum | DRM | DRM% | DRM% Sum | DRM | DRM% | DRM% Sum | DRM | DRM% | DRM% Sum | DRM | DRM% | DRM% Sum | DRM | DRM% | DRM% Sum | DRM | DRM% | DRM% Sum |
| K103N | 53.4 | 53.4 | K103N | 67.8 | 67.8 | K103N | 53.3 | 53.3 | K103N | 45.7 | 45.7 | K103N | 52.4 | 52.4 | Y181C | 43.2 | 43.2 | K103N | 68.3 | 68.3 |
| Y181C | 28.8 | 100 | Y181C | 13.6 | 100 | Y181C | 23.7 | 100 | G190A | 28.3 | 100 | Y181C | 23.8 | 100 | K103N | 38.3 | 100 | Y181C | 22.0 | 100 |
| G190A | 9.6 | 100 | G190A | 11.4 | 100 | G190A | 17.8 | 100 | Y181C | 19.6 | 100 | Y188L | 19.0 | 100 | G190A | 17.3 | 100 | G190A | 14.6 | 100 |
| Y181I | 2.7 | 100 | Y188L | 5.4 | 100 | V106M | 5.9 | 100 | L100I | 6.5 | 100 | G190A | 9.5 | 100 | G190E | 3.7 | 100 | G190E | 4.9 | 100 |
| Y181V | 2.7 | 100 | K103S | 4.0 | 100 | K103S | 4.4 | 100 | Y188H | 4.3 | 100 | Y188C | 4.8 | - | G190S | 3.7 | 100 | G190S | 2.4 | - |
| Y188C | 2.7 | 100 | L100I | 2.3 | 100 | Y181I | 3.0 | 100 | G190E | 2.2 | 100 | G190E | 0 | | V106M | 3.7 | 100 | G190Q | 0 | |
| G190E | 1.4 | 100 | G190S | 1.8 | 100 | L100I | 1.5 | 100 | K103S | 2.2 | - | G190Q | 0 | | M230L | 2.5 | 100 | K101P | 0 | |
| L100I | 1.4 | 100 | Y188H | 1.7 | 100 | Y188L | 1.5 | 100 | G190Q | 0 | | G190S | 0 | | Y188C | 2.5 | 100 | K103S | 0 | |
| V106A | 1.4 | 100 | V106A | 1.6 | 100 | G190E | 0.7 | 100 | G190S | 0 | | K101P | 0 | | V106A | 1.2 | 100 | L100I | 0 | |
| Y188L | 1.4 | 100 | M230L | 1.2 | 100 | G190S | 0.7 | 100 | K101P | 0 | | K103S | 0 | | Y181I | 1.2 | 100 | M230L | 0 | |
| K101P | 1.4 | - | Y188C | 1.2 | 100 | Y188C | 0.7 | 100 | M230L | 0 | | L100I | 0 | | K103S | 3.7 | - | V106A | 0 | |
| K103S | 1.4 | - | K101P | 1.1 | 100 | K101P | 0.7 | - | V106A | 0 | | M230L | 0 | | L100I | 1.2 | - | V106M | 0 | |
| M230L | 1.4 | - | G190E | 0.8 | 100 | M230L | 0.7 | - | V106M | 0 | | V106A | 0 | | G190Q | 0 | | Y181I | 0 | |
| G190Q | 0 | | V106M | 0.7 | 100 | G190Q | 0 | | Y181I | 0 | | V106M | 0 | | K101P | 0 | | Y181V | 0 | |
| G190S | 0 | | Y181I | 0.5 | 100 | V106A | 0 | | Y181V | 0 | | Y181I | 0 | | Y181V | 0 | | Y188C | 0 | |
| V106M | 0 | | Y181V | 0.2 | 100 | Y181V | 0 | | Y188C | 0 | | Y181V | 0 | | Y188H | 0 | | Y188H | 0 | |
| Y188H | 0 | | G190Q | 0 | | Y188H | 0 | | Y188L | 0 | | Y188H | 0 | | Y188L | 0 | | Y188L | 0 | |
Footnotes:
- The prevalence of all DRMs including those with lower scores can be queried using the form at the following page: Prevalence of DRMs in ARV-Naive Patients